Strides Pharma Science Ltd Q1 FY24 consolidated loss at Rs. 7.11 crores

Strides Pharma Science Limited has reported Consolidated financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 938.639 crores during the period ended June 30, 2023 as compared to Rs. 1013.491 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. -7.113 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. -9.542 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. -0.79 for the period ended June 30, 2023 as compared to Rs. -1.06 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 938.639 crs	₹1013.491 crs	-7.39%
Net Profit	₹-7.113 crs	₹-9.542 crs	25.46%
EPS	₹-0.79	₹-1.06	25.47%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 938.639 crores during the period ended June 30, 2023 as compared to Rs.953.622 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.-7.113 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.-135.892 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.-0.79 for the period ended June 30, 2023 as compared to Rs.-15.13 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 938.639 crs	₹953.622 crs	-1.57%
Net Profit	₹-7.113 crs	₹-135.892 crs	94.77%
EPS	₹-0.79	₹-15.13	94.78%

Shares of Strides Pharma Science Limited was last trading in BSE at Rs. 480.20 as compared to the previous close of Rs. 472.10. The total number of shares traded during the day was 57214 in over 2164 trades.

The stock hit an intraday high of Rs. 488.85 and intraday low of 473.15. The net turnover during the day was Rs. 27493887.00.

Source : Equity Bulls

Keywords

StridesPharmaScience Q1FY24 ResultUpdate